Early outcomes of transapical mitral valve implantation versus surgical replacement in matched elderly patients at intermediate surgical risk

CONCLUSIONS: Patients with intermediate surgical risk, according to STS-PROM and EuroSCORE II, demonstrated higher rates of MVARC device at 30 days after TMVI compared to 30 days after SMVR. Rates of survival and procedural success, neurological, renal and bleeding complications were similar. Transfusion count and length of stay were lower after TMVI. For elderly patients at intermediate risk, a TMVI eligibility assessment may be considered.PMID:38436368 | PMC:PMC10905192 | DOI:10.4244/EIJ-D-23-00734

Source: EuroIntervention - March 4, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Johannes A Ziegelmueller Melchior Burri Andreas Stein Peter Tassani-Prell Markus Krane R üdiger Lange Hendrik Ruge Source Type: research